Ron Chiarello PhD, Founder, CEO and Chairman of the Board, Alveo Technologies talks about the need for a low-cost, easy-to-use diagnostic platform to allow more people to detect and manage an infectious disease like COVID-19. Winning the XPRIZE Rapid COVID-19 Testing Competition has highlighted their be.well diagnostic platform which uses an at-home system to take a nasal swab that gets placed in a disposable cartridge that goes into an analyzer that communicates to a mobile device with RNA-based test results in less than 30 minutes.
#COVID19 #COVIDVaccine #COVIDTesting #InfectiousDisease #PublicHealth
AlveoTechnologies.com
Download the transcript here
Empowered Patient Podcast